share_log

Appili Therapeutics Inc: CONSENT LETTER OF ISSUER'S LEGAL COUNSEL

SEDAR ·  May 21, 2022 01:43
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.